Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Gift Chiwala"'
Autor:
Buhari Yusuf, Shuai Wang, Md Shah Alam, Jingran Zhang, Zhiyong Liu, Ziwen Lu, Jie Ding, Gift Chiwala, Yamin Gao, Cuiting Fang, Shahzad Akbar Khan, Xirong Tian, Md Mahmudul Islam, H. M. Adnan Hameed, Dmitry A. Maslov, Nanshan Zhong, Jinxing Hu, Tianyu Zhang
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 10 (2024)
ABSTRACT The increasing clinical significance of Mycobacterium abscessus is owed to its innate high-level, broad-spectrum resistance to antibiotics and therefore rapidly evolves as an important human pathogen. This warrants the identification of nove
Externí odkaz:
https://doaj.org/article/2fa01b2e3deb4ca0a395ca048b52a533
Autor:
Clara Ngoliwa, Kondwani Jambo, Neema Toto, Vitumbiko S. Nkhoma, Lorensio Chimgoneko, Marc Henrion, Lumbani Makhaza, John Ndaferankhande, Stephen B. Gordon, Gift Chiwala, Gareth Lipunga, Anthony Emeritus Chirwa, Bridgette Galafa, Faith Thole, Evarista Kudowa, Morrison Peace Kamanga, Godwin Tembo, Dingase Dula, Daniela M. Ferreira, Tarsizio Chikaonda, Ndaziona Peter Kwanjo Banda, Edna Nsomba
Publikováno v:
Wellcome Open Research, Vol 9 (2024)
Background Streptococcus pneumoniae is a major cause of morbidity and mortality from respiratory tract infections, pneumonia, meningitis, and sepsis. Nasopharyngeal carriage of pneumococcus is a prerequisite for pneumococcal disease and transmission.
Externí odkaz:
https://doaj.org/article/c01b3e2b0cc342a49260484f2f7a941c
Autor:
Angela Hyder-Wright, Anthony Chirwa, Anthony E. Chirwa, Kondwani Jambo, Ben Morton, Emma Carter, Tinashe Kenny-Nyazika, Dima ElSafadi, Jonathan Gonzalez Sanchez, Gift Chiwala, Giancarlo Biagini, Vincent Yip, Paula Saunderson, Shaun H. Pennington, Christopher Myerscough, Madlen Farrar, Andrea M. Collins, Kelly Convey, Daniela M. Ferreira, Tarsizio Chikaonda, Stephen B. Gordon
Publikováno v:
Wellcome Open Research, Vol 8 (2024)
Tuberculosis (TB) caused 1.5 million deaths in 2020, making it the leading infectious killer after COVID-19. Bacille Calmette-Guerin (BCG) is the only licensed vaccine against TB but has sub-optimal efficacy against pulmonary TB and reduced effective
Externí odkaz:
https://doaj.org/article/98c17705dfc6491aa73d483ec7ff6050
Autor:
Gift Chiwala, Zhiyong Liu, Julius N. Mugweru, Bangxing Wang, Shahzad Akbar Khan, Petuel Ndip Ndip Bate, Buhari Yusuf, H.M. Adnan Hameed, Cuiting Fang, Yaoju Tan, Ping Guan, Jinxing Hu, Shouyong Tan, Jianxiong Liu, Nanshan Zhong, Tianyu Zhang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112047- (2021)
Drug-resistant tuberculosis (DR-TB) poses a new threat to global health; to improve the treatment outcome, therapeutic vaccines are considered the best chemotherapy adjuvants. Unfortunately, there is no therapeutic vaccine approved against DR-TB. Our
Externí odkaz:
https://doaj.org/article/e81490eaa1994df8be39238fad6500c3
Autor:
Yang Liu, Yamin Gao, Jianxiong Liu, Yaoju Tan, Zhiyong Liu, Chiranjibi Chhotaray, Huofeng Jiang, Zhili Lu, Gift Chiwala, Shuai Wang, Gaelle Makafe, Md Mahmudul Islam, H. M. Adnan Hameed, Xingshan Cai, Changwei Wang, Xinjie Li, Shouyong Tan, Tianyu Zhang
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-9 (2019)
Combination therapy for Buruli ulcer (BU) is suboptimal. Here, Liu et al. show that the candidate drug TB47 has potent bactericidal activity against Mycobacterium ulcerans in vitro and in a mouse model, which underscores its potential for shortening
Externí odkaz:
https://doaj.org/article/3eb099eeaf12439699ea5255f9ccaab6
Autor:
Wei Yu, Gift Chiwala, Yamin Gao, Zhiyong Liu, Sanjeep Sapkota, Zhili Lu, Lingmin Guo, Shahzad Akbar Khan, Nanshan Zhong, Tianyu Zhang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 131, Iss , Pp 110782- (2020)
Multidrug-resistant tuberculosis (MDR-TB) remains a serious public health threat worldwide. To date, the anti-TB activity of TB47 (T), an imidazopyridine amide class of antibiotics targeting QcrB in the electron transport chain, has not been systemat
Externí odkaz:
https://doaj.org/article/30e771fad8bf497cb9466fc1b38c7b92
Autor:
HM Adnan Hameed, Cuiting Fang, Zhiyong Liu, Yanan Ju, Xingli Han, Yamin Gao, Shuai Wang, Gift Chiwala, Yaoju Tan, Ping Guan, Jinxing Hu, Xiaoli Xiong, Jiacong Peng, Yongping Lin, Muzammal Hussain, Nanshan Zhong, Dmitry A Maslov, Gregory M Cook, Jianxiong Liu, Tianyu Zhang
Publikováno v:
Infection and Drug Resistance.
HM Adnan Hameed1â 4*, Cuiting Fang1â 4*, Zhiyong Liu,1â 3 Yanan Ju,1â 3 Xingli Han,1â 4 Yamin Gao,1â 4 Shuai Wang,1â 3,5 Gift Chiwala,1â 4 Yaoju Tan,6 Ping Guan,6 Jinxing Hu,6 Xiaoli Xiong,1â 3 Jia
Autor:
H M Adnan, Hameed, Cuiting, Fang, Zhiyong, Liu, Yanan, Ju, Xingli, Han, Yamin, Gao, Shuai, Wang, Gift, Chiwala, Yaoju, Tan, Ping, Guan, Jinxing, Hu, Xiaoli, Xiong, Jiacong, Peng, Yongping, Lin, Muzammal, Hussain, Nanshan, Zhong, Dmitry A, Maslov, Gregory M, Cook, Jianxiong, Liu, Tianyu, Zhang
Publikováno v:
Infection and drug resistance. 15
Rifampicin (RIF)-resistance, a surrogate marker for multidrug-resistant tuberculosis (TB), is mediated by mutations in theAmong 465 clinical isolates collected from the Guangzhou Chest Hospital, drug-susceptibility of 175 confirmedWe found 150/175 (8
Autor:
Xirong Tian, Shah Alam, Zhili Lu, Gift Chiwala, Nanshan Zhong, H.M. Adnan Hameed, Shuai Wang, Wei Yu, Gregory M. Cook, Tianyu Zhang, D. A. Maslov, Buhari Yusuf
Publikováno v:
Antimicrob Agents Chemother
Toxicity and inconvenience associated with the use of injectable drug-containing regimens for tuberculosis (TB) have made all-oral regimens a preferred alternative. Widespread resistance to fluoroquinolones and pyrazinamide makes it essential to iden
Autor:
Yaoju Tan, Ping Guan, Nanshan Zhong, Jinxing Hu, Julius Mugweru, Gift Chiwala, Tianyu Zhang, Jianxiong Liu, Petuel Ndip Ndip Bate, Buhari Yusuf, Shouyong Tan, Bangxing Wang, H.M. Adnan Hameed, Shahzad Akbar Khan, Cuiting Fang, Zhiyong Liu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112047-(2021)
Drug-resistant tuberculosis (DR-TB) poses a new threat to global health; to improve the treatment outcome, therapeutic vaccines are considered the best chemotherapy adjuvants. Unfortunately, there is no therapeutic vaccine approved against DR-TB. Our